These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25962684)

  • 1. Role of chemokine CX3CL1 in progression of multiple myeloma via CX3CR1 in bone microenvironments.
    Wada A; Ito A; Iitsuka H; Tsuneyama K; Miyazono T; Murakami J; Shibahara N; Sakurai H; Saiki I; Nakayama T; Yoshie O; Koizumi K; Sugiyama T
    Oncol Rep; 2015 Jun; 33(6):2935-9. PubMed ID: 25962684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of CX3CL1/fractalkine in osteoclast differentiation and bone resorption.
    Koizumi K; Saitoh Y; Minami T; Takeno N; Tsuneyama K; Miyahara T; Nakayama T; Sakurai H; Takano Y; Nishimura M; Imai T; Yoshie O; Saiki I
    J Immunol; 2009 Dec; 183(12):7825-31. PubMed ID: 19923448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The involvement of the fractalkine receptor in the transmigration of neuroblastoma cells through bone-marrow endothelial cells.
    Nevo I; Sagi-Assif O; Meshel T; Ben-Baruch A; Jöhrer K; Greil R; Trejo LE; Kharenko O; Feinmesser M; Yron I; Witz IP
    Cancer Lett; 2009 Jan; 273(1):127-39. PubMed ID: 18778890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of CX3CR1/CX3CL1 axis in primary and secondary involvement of the nervous system by cancer.
    Marchesi F; Locatelli M; Solinas G; Erreni M; Allavena P; Mantovani A
    J Neuroimmunol; 2010 Jul; 224(1-2):39-44. PubMed ID: 20630606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular expression of the chemokine CX3CL1 promotes osteoclast recruitment and exacerbates bone resorption in an irradiated murine model.
    Han KH; Ryu JW; Lim KE; Lee SH; Kim Y; Hwang CS; Choi JY; Han KO
    Bone; 2014 Apr; 61():91-101. PubMed ID: 24401612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CC chemokine MCP-1 stimulates surface expression of CX3CR1 and enhances the adhesion of monocytes to fractalkine/CX3CL1 via p38 MAPK.
    Green SR; Han KH; Chen Y; Almazan F; Charo IF; Miller YI; Quehenberger O
    J Immunol; 2006 Jun; 176(12):7412-20. PubMed ID: 16751386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Fractalkine-Receptor Axis Improves Human Colorectal Cancer Prognosis by Limiting Tumor Metastatic Dissemination.
    Erreni M; Siddiqui I; Marelli G; Grizzi F; Bianchi P; Morone D; Marchesi F; Celesti G; Pesce S; Doni A; Rumio C; Roncalli MG; Laghi L; Mantovani A; Allavena P
    J Immunol; 2016 Jan; 196(2):902-14. PubMed ID: 26673138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory effects of resistin on human smooth muscle cells: up-regulation of fractalkine and its receptor, CX3CR1 expression by TLR4 and Gi-protein pathways.
    Gan AM; Butoi ED; Manea A; Simion V; Stan D; Parvulescu MM; Calin M; Manduteanu I; Simionescu M
    Cell Tissue Res; 2013 Jan; 351(1):161-74. PubMed ID: 23086480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment.
    Ferretti E; Bertolotto M; Deaglio S; Tripodo C; Ribatti D; Audrito V; Blengio F; Matis S; Zupo S; Rossi D; Ottonello L; Gaidano G; Malavasi F; Pistoia V; Corcione A
    Leukemia; 2011 Aug; 25(8):1268-77. PubMed ID: 21546901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-κB-mediated inverse regulation of fractalkine and CX3CR1 during CLP-induced sepsis.
    Raspé C; Höcherl K; Rath S; Sauvant C; Bucher M
    Cytokine; 2013 Jan; 61(1):97-103. PubMed ID: 23026294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertrophy of the ligament flavum in degenerative lumbar stenosis associated with the increased expression of fractalkine (CX3CL1)/CX3CR1 chemokine.
    Oh IS; Suh DW; Ha KY
    Connect Tissue Res; 2013; 54(6):380-5. PubMed ID: 24060055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RANKL-induced down-regulation of CX3CR1 via PI3K/Akt signaling pathway suppresses Fractalkine/CX3CL1-induced cellular responses in RAW264.7 cells.
    Saitoh Y; Koizumi K; Sakurai H; Minami T; Saiki I
    Biochem Biophys Res Commun; 2007 Dec; 364(3):417-22. PubMed ID: 17963723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chemokine CX3CL1 (fractalkine) and its receptor CX3CR1: occurrence and potential role in osteoarthritis.
    Wojdasiewicz P; Poniatowski LA; Kotela A; Deszczyński J; Kotela I; Szukiewicz D
    Arch Immunol Ther Exp (Warsz); 2014 Oct; 62(5):395-403. PubMed ID: 24556958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated expression of CX3C chemokine receptor 1 mediates recruitment of T cells into bone marrow of patients with acquired aplastic anaemia.
    Ren J; Hou XY; Ma SH; Zhang FK; Zhen JH; Sun L; Sun YX; Hao YL; Cheng YF; Hou M; Xu CG; Zhang MH; Peng J
    J Intern Med; 2014 Nov; 276(5):512-24. PubMed ID: 24528288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CX3CL1/CX3CR1-mediated microglia activation plays a detrimental role in ischemic mice brain via p38MAPK/PKC pathway.
    Liu Y; Wu XM; Luo QQ; Huang S; Yang QW; Wang FX; Ke Y; Qian ZM
    J Cereb Blood Flow Metab; 2015 Oct; 35(10):1623-31. PubMed ID: 25966946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis--possible role in vascular inflammation.
    Bjerkeli V; Damås JK; Fevang B; Holter JC; Aukrust P; Frøland SS
    Rheumatology (Oxford); 2007 Sep; 46(9):1422-7. PubMed ID: 17616549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells.
    Oba Y; Lee JW; Ehrlich LA; Chung HY; Jelinek DF; Callander NS; Horuk R; Choi SJ; Roodman GD
    Exp Hematol; 2005 Mar; 33(3):272-8. PubMed ID: 15730850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CX3CL1/CX3CR1 reprograms glucose metabolism through HIF-1 pathway in pancreatic adenocarcinoma.
    Ren H; Zhao T; Sun J; Wang X; Liu J; Gao S; Yu M; Hao J
    J Cell Biochem; 2013 Nov; 114(11):2603-11. PubMed ID: 23857671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy.
    Damås JK; Boullier A; Waehre T; Smith C; Sandberg WJ; Green S; Aukrust P; Quehenberger O
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2567-72. PubMed ID: 16224053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesis.
    Celesti G; Di Caro G; Bianchi P; Grizzi F; Marchesi F; Basso G; Rahal D; Delconte G; Catalano M; Cappello P; Roncalli M; Zerbi A; Montorsi M; Novelli F; Mantovani A; Allavena P; Malesci A; Laghi L
    Br J Cancer; 2013 Oct; 109(9):2424-33. PubMed ID: 24084767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.